The Mosaic Company (MOS)
(Delayed Data from NYSE)
$28.65 USD
+0.13 (0.46%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $28.65 0.00 (0.00%) 7:16 PM ET
5-Strong Sell of 5 5
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$28.65 USD
+0.13 (0.46%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $28.65 0.00 (0.00%) 7:16 PM ET
5-Strong Sell of 5 5
A Value C Growth F Momentum B VGM
Zacks News
MOS or SQM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOS vs. SQM: Which Stock Is the Better Value Option?
Upgraded Broker Ratings Make These 5 Stocks Worth a Look Now
by Swayta Shah
After in-depth research, brokers rate a company's stock. Hence, we select Tenet Healthcare (THC), Avery Dennison (AVY), ArcBest (ARCB), Mosaic Company (MOS) & Installed Building Products (IBP) as these witness ratings upgrade.
Are Options Traders Betting on a Big Move in Mosaic (MOS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Mosaic (MOS) stock based on the movements in the options market lately.
Mosaic (MOS) Partners With BioConsortia for Microbial Products
by Zacks Equity Research
Mosaic (MOS) enters into an agreement with BioConsortia for developing new nitrogen-fixing microbial products to boost crop yield.
Mosaic (MOS) Up 26.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Mosaic (MOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mosaic (MOS) Declares October Sales Volumes & Revenues
by Zacks Equity Research
Mosaic's (MOS) sales volume and revenues in the Potash and Phosphates units rise year over year in October.
Mosaic's (MOS) Earnings Beat, Sales Miss Estimates in Q3
by Zacks Equity Research
Lower prices hurt Mosaic's (MOS) Potash segment sales in the third quarter.
Mosaic (MOS) Q3 Earnings Top Estimates
by Zacks Equity Research
Mosaic (MOS) delivered earnings and revenue surprises of 4.55% and -1.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Mosaic (MOS) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Mosaic's (MOS) Q3 performance is likely to reflect the benefits of phosphate fertilizer products prices and higher volumes at Mosaic Fertilizantes and Phosphates units.
3 Fertilizer Stocks Worth a Look Amid Pricing Woes
by Nilanjan Gupta
Lower fertilizer prices are hurting the Zacks Fertilizers industry's prospects. Key players like Nutrien (NTR), Scotts Miracle-Gro (SMG) and Mosaic (MOS) should gain from improving demand.
Mosaic (MOS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Mosaic (MOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is There Anything Like a Safe Stock Right Now?
by Sejuti Banerjea
Safety is a prime consideration when thinking about stocks in this environment.
Will Mosaic (MOS) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Mosaic (MOS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Is Mosaic (MOS) Up 20.4% Since Last Earnings Report?
by Zacks Equity Research
Mosaic (MOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Mosaic Company's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Mosaic Company
3 Agriculture-Focused Stocks With a Bright Future
by Sejuti Banerjea
There are some bright spots in the agricultural market that is still reeling from the effects of the pandemic.
5 Top-Ranked Stocks Powering S&P 500's Fastest-Ever Recovery
by Sweta Killa
The S&P 500 rebound from the trough to a peak marks the fastest-ever recovery from a bear market in the history of the index.
Mosaic (MOS) Declares July Sales Volumes & Revenues of Units
by Zacks Equity Research
Mosaic's (MOS) sales volume and revenues in the Phosphates unit rise year over year in July.
Mosaic (MOS) in Focus: Stock Moves 7% Higher
by Zacks Equity Research
Mosaic (MOS) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Mosaic's (MOS) Earnings and Sales Surpass Estimates in Q2
by Zacks Equity Research
Lower prices hurt Mosaic's (MOS) sales across business segments in Q2
Mosaic (MOS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Mosaic (MOS) delivered earnings and revenue surprises of 375.00% and 9.25%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Mosaic (MOS) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Mosaic's (MOS) second-quarter 2020 results are likely to reflect the benefits of strong demand for fertilizers application in North America and Brazil.
Earnings Preview: Mosaic (MOS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Mosaic (MOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bear of the Day: Nutrien (NTR)
by Tracey Ryniec
2020 will not be the turnaround year for the fertilizers after all.
Near-Term Outlook for Fertilizers Industry Appears Bleak
by Nilanjan Gupta
Weak crop nutrient prices amid a difficult global environment are likely to eat into margins of industry participants.